Tue, October 11, 2022

Matthew Harrison Upgraded (AMGN) to Buy and Increased Target to $279 on, Oct 11th, 2022

Matthew Harrison of Morgan Stanley, Upgraded "Amgen Inc." (AMGN) to Buy and Increased Target from $257 to $279 on, Oct 11th, 2022.

Matthew has made no other calls on AMGN in the last 4 months.



There are 3 other peers that have a rating on AMGN. Out of the 3 peers that are also analyzing AMGN, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $236 on, Friday, August 5th, 2022


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Steve Chesney of "Atlantic Equities" Maintained at Sell with Decreased Target to $182 on, Tuesday, August 9th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $265 on, Friday, August 5th, 2022